AI assistant
Sending…
SUPERNUS PHARMACEUTICALS, INC. — Director's Dealing 2012
Apr 30, 2012
31512_dirs_2012-04-30_8220cf33-c0c7-4e52-9114-28165e0467eb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SUPERNUS PHARMACEUTICALS INC (SUPN)
CIK: 0001356576
Period of Report: 2012-04-30
Reporting Person: BIGHAM MICHAEL (Director)
More from SUPERNUS PHARMACEUTICALS, INC.
Capital/Financing Update
2026
Jun 22
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 18
Call Transcript
2026
Jun 3
Regulatory Filings
2026
May 20
Call Transcript
2026
May 13
Call Transcript
2026
May 5
Regulatory Filings
2026
Apr 22
Capital/Financing Update
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 18